Polypeptide and the use thereof
AssigneesNational Cerebral and Cardiovascular Center, Takeda Pharmaceutical Company Limited
InventorsKenji Kangawa, Kenji Mori, Mikiya Miyazato, Masayasu Kojima
Life of this patent
Estimating the term…
Loading patent…
AssigneesNational Cerebral and Cardiovascular Center, Takeda Pharmaceutical Company Limited
InventorsKenji Kangawa, Kenji Mori, Mikiya Miyazato, Masayasu Kojima
Estimating the term…
The present invention provides a variety of useful polypeptides. In particular, a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, its amide, or a salt thereof can be used as an agent for preventing/treating hypotension; an agent for preventing/treating obesity, hyperphagia, etc.; an agent for preventing/treating lethargy, time-zone change syndrome (jet lag), etc.; an agent for preventing/treating sterility, etc. A compound or its salt that promotes the activity of a polypeptide comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by any of SEQ ID NOS: 7 to 12 and 37 to 42, its partial peptide, or a salt thereof is useful as an agent for preventing/treating, e.g., menopausal symptoms or hyperthyroidism. A compound or its salt that inhibits the activity of said polypeptide is useful as an agent for preventing/treating, e.g., sterility or hypothyroidism.
An isolated polypeptide, which comprises the amino acid sequence represented by SEQ ID NO:
An isolated polypeptide, which comprises an amino acid sequence at least 90% identical to the amino acid sequence represented by SEQ ID NO:
An isolated polypeptide, which comprises an amino acid sequence at least 95% identical to the amino acid sequence represented by SEQ ID NO:
An isolated polypeptide, which consists of the amino acid sequence represented by SEQ ID NO:
Dependencies are inferred from the claim text.